trial
as of 2026-07-01Dopamine D2 and D3 Receptor Occupancy and Clinical Response in Older Patients With Schizophrenia
NCTId NCT00825045
at a glance
— · Unknown
Enrollment 14 (estimated)
Sponsored by Centre for Addiction and Mental Health
Primary completion 2020-12
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Unknown
Enrollment
14 (estimated)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2008-12
Primary completion
2020-12
Eligibility
ALL · 50 Years
Interventions & indications
Sponsors
Centre for Addiction and Mental HealthLead Sponsor
Investigators
1
Ariel Graff-Guerrero, MD, PhDPrincipal Investigator
Sites
1 total
Toronto, Canada
Facts & assertions
4 sourced
Enrollment
14
Phase
NA
Primary Completion Date
2020-12
Status
UNKNOWN
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator